Discovery of innate immune receptor "brake" Siglec-E offers a novel therapeutic target to prevent organ transplant rejection ...

An expert discusses how effective blastic plasmacytoid dendritic cell neoplasm (BPDCN) management requires early central ...

An expert discusses how treatment selection in blastic plasmacytoid dendritic cell neoplasm (BPDCN) involves balancing ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor cells are easily recognizable by the immune system. In addition, they are ...

Other cell types, such as dendritic cells, regulatory T cells ... marker CD68 in the analysis of IDO1 and PDL1 expression in skin tissue, and how does this relate to parasite burden?

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make one of the most aggressive forms of melanoma more treatable.

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...